Stanford Biodesign - Supporters

Venture Partners

Our Venture Partners help shape educational program development and participate as speakers and moderators at Biodesign events. Venture Partners may also assist with market evaluation and technology assessment as well as providing contacts and resources for development/incubation of new technologies. For more information about the Biodesign Venture Partners Program, please contact Ari Chaney at (650) 736-1159 or by email: achaney@stanford.edu

Profile:: Founded in 1979, Advanced Technology Ventures (ATV) is a bi-coastal venture capital firm with more than $1.4 billion in capital under management. We work closely with entrepreneurial teams in several technology markets, including communications, infrastructure, software and services, consumer technology, biopharmaceuticals, medical devices and emerging technologies, to build emerging-growth business ventures into market leaders. With more than 25 years of experience, ATV has a proven track record of success in helping to build strong, sustainable business enterprises.
Contact Advanced Technology Ventures:: 485 Ramona Street, Palo Alto, CA 94301
650.321.8601
Michael Carusi

Profile:: At Artiman Ventures, we focus our energies on helping talented entrepreneurs commercialize leading edge technologies to create world class companies. We are actively involved with our entrepreneurs from the earliest stages of company creation in distilling ideas and opportunities, brainstorming, refining business plans, building high energy teams, developing channel partners and customers, and syndicating venture financings.
Contact Artiman Ventures:: 2000 University Ave, Suite 602, East Palo Alto, CA 94303
650.845.2020
Amit Shah
Saurabh Srivastava
Yatin Mundkur

Profile:: The partners at Delphi Ventures help build healthcare companies. Delphi has been the lead or co-lead investor in more than 75% of its investments. Delphi prefers to be active in its investments, taking Board seats and working closely with our companies' management teams. We provide capital, contacts and leadership. While most of our investments are in the western U.S., we are willing to invest anywhere in the U.S. under the proper circumstances. Delphi focuses its investments on medical devices and diagnostics, biotechnology, and healthcare services
Contact Delphi Ventures:: 3000 Sand Hill Road, Building 1, Suite 135, Menlo Park, CA 94025
650.854.9650
David Douglass

John Maroney

Profile:: De Novo Ventures, founded in 2000, invests in early stage life science companies that focus on therapeutic medical devices and biotechnology. These include emerging device opportunities in cardiology, neurology, ophthalmology, orthopedics, plastics, gastroenterology, pulmonology, and biotech companies with initial human clinical experience. De Novo has $350 million under management and its portfolio includes over 20 medical device and biotechnology compan ies. Located in Palo Alto, California, the firm invests nationally with a focus on the Western US. De Novo Ventures is highly regarded among active entrepreneurs because of its team's significant operating and investment experience. As entrepreneurs, the fund managers personally have founded or co-founded 10 companies including Advanced Cardiovascular Systems, CardioThoracic Systems, Origin Medsystems, Gynecare, and Perclose. De Novo Ventures encourages young companies to take a look at the substantial impact that its team can have on their businesses.
Contact De Novo Ventures:: 400 Hamilton Ave, Suite 300, Palo Alto, CA 94301
650.329.1999

Kathryn Cavanaugh
Frederick Dotzler
Richard Ferrari
Joe Mandato
David Mauney, MD
Jay Watkins

Profile:: HLM Venture Partners is a proven, successful venture capital health care investor. Over 60 privately held health care companies have benefited from our expertise, resources and commitment. Emerging health care companies can be confident that HLM Venture Partners’ longevity, integrity and reputation will be invaluable assets as we work together to transform their innovative ideas into market-leading businesses.
Contact HLM Venture Partners:: 201 Mission Street, Suite 2240
San Francisco, CA 94105
415-814-6110
Dan Galles
Al Wiegman
Ed Cahill
Teo Dagi
Russ Ray
Yumin Choi
Enrico Picozz
Peter Grua
Vin Fabiani
Marty Felsenthal

Profile:: InterWest invests an average of about 5 million dollars over the span of our involvement with each company in our portfolio. We invest in companies through the full range of venture investment stages, and investments may be staged over several rounds of financing. Although we generally begin our involvement in the early stages of a company's development, we pursue attractive opportunities based on their individual merits rather than their investment stage. InterWest is the lead investor in more than 70-percent of the investments we make, reflecting our ability to marshal resources and organize financings on behalf of our portfolio companies. We maintain relationships with our portfolio companies for an average of 4 years and in some cases for 10 years or more. An InterWest general partner serves as a director for 85-percent of the companies in our portfolio, often continuing to serve even after the partnership's investment in the company has been returned. This high level of personal commitment enables us to deliver on our fundamental promise to the entrepreneurs we back: to add value beyond the capital we contribute.
Contact Interwest Partners:: 2710 Sand Hill Road, Second Floor, Menlo Park, CA 94025
650.854.8585
Chris Ehrlich
Nina Kjellson; Gilbert Kliman, MD
Ellen Koskinas
Dr. Arnold Oronsky
Michael Sweeney

Profile:: With over $330 million in capital under management, Kearny Venture Partners is a venture capital firm exclusively focused on healthcare products. We believe that the opportunity for entrepreneurs to devise innovative solutions in healthcare has never been greater. Significant unmet needs in healthcare continue to persist, representing large potential market opportunities for safe and effective products. As the molecular basis of disease is increasingly unraveled, new opportunities for intervention emerge. Novel therapies can and will displace incumbent products.
Contact Kearny Venture Partners:: 88 Kearny Street, 5th Floor, San Francisco, CA 94108-5530
415.364.5999
Jim Shapiro

Profile:: In 1972, KPCB began offering entrepreneurs a broader philosophy of value-added investing: not merely access to capital, but access to people. A partnership with experienced industry leaders who recognize, challenge, and even improve on a brilliant idea. We believe that we must earn the right to advise entrepreneurs on a daily basis, by intellectually committing to deliver the best ideas of which we are capable. We are here to build on your vision. Strengthen strategic thinking. Tap the industry network. Access talent. Pull strings. Sew up financing. And stick with you through every challenge along the way.
Contact Kleiner Perkins:: 2750 Sand Hill Road Menlo Park CA 94025
650.233.2750
Brook Byers
Joseph Lacob
Dana Mead, PhD
Risa Stack

Profile:: Founded in 2006, Longitude Capital is a venture capital firm that invests in medical device and biotechnology companies developing products that address important unmet medical or economic needs in the life sciences industry. Longitude’s investment team has more than 100 years of industry experience and has invested in over 100 life sciences companies. We are active, lead investors who work closely with portfolio companies to achieve corporate objectives and build value for our limited partners. Our inaugural fund, the $325,000,000 Longitude Venture Partners, L.P., was closed in 2008. Our offices are in Menlo Park, California and Greenwich, Connecticut.
Contact Longitude Capital:: 800 El Camino Real, Suite 220, Menlo Park, CA 94025
650.854.5700
Jeff Gold

Profile:: MDV invests in innovative entrepreneurs with deep expertise in energy and materials, Internet services; life sciences, semiconductor and software and systems. Our venture capital team engages very early in the life of a company to impact its long-term success. We apply years of real-world experience to accelerate each company's time to market and optimize its success.

For more than 20 years, our mission as an early stage venture capital firm has been to identify, invest in, mentor and develop venture-backed companies that redefine how organizations and individuals apply new technologies and scientific advances.
Contact Mohr Davidow Ventures:: 3000 Sand Hill Road, Bldg 3, Suite 290, Menlo Park, CA 94025
650-854-7236; Rowan Chapman
Bill Ericson
Michael Goldberg
Michael Lanham

Profile:: Founded in 1993, Montreux Equity Partners, based in Menlo Park, CA, is a li fe sciences focused venture capital firm that invests in new and emerging pharma ceutical, biopharmaceutical and medical device companies that bring important th erapeutic benefits to patients and their physicians.

Montreux has over $ 170 million under management and is currently investing out of funds with over $ 150 million in capital. Montreux investment ranges from $2-$5 million in any giv en financing and up to $10 million over the life cycle of the investment.
Contact Montreux Equity Partners:: 3000 Sand Hill Road, Building 1, Suite 260, Menlo Park, CA 94025
650.234.1200; Manish Chapekar
Howard Palefsky
John Savarese, MD
Daniel Turner

Profile:: Morgenthaler Ventures has worked with outstanding entrepreneurs to build valuable companies for more than 40 years. They have $2.5 billion under management, including $450 million in their current fund (capitalized in October of 2005). Today, their venture capital team focuses its investments in two areas: Information technology and life sciences. Headquartered in Menlo Park, CA, with offices in Boulder, CO; Boston, MA; Cleveland, OH and Princeton, NJ, their passion for company building has earned the respect of their partners and exceptional results for their investors.
Contact Morgenthaler:: 2710 Sand Hill Road, Suite 100, Menlo Park, CA 94025
650.388.7600
http://www.morgenthaler.com/; Hank Plain

Profile:: New Enterprise Associates (NEA) is one of the industry's premier venture capital firms. For 21 years, NEA has practiced classic venture capital by investing in early-stage companies and working with management to nurture and build companies of real and lasting value. NEA is now the leading start-up venture investor in the country. NEA shares characteristics with other venture firms but differs in many ways: its size and scope, the number of successful companies it has financed, its geographic reach, the experience and expertise of its partners and its commitment to its entrepreneurs and their companies. Since inception in 1978, more than 100 NEA companies have gone public; more than 60 since 1991.
Contact NEA:: 2855 Sand Hill Road Menlo Park, CA 94025
650.854.9499
Robert Garland, MD
Chip Linehan
Mohamad Makhzoumi
Josh Makower, MD
Sigrid VanBladel

Profile:: ONSET Ventures is a 20-year-old venture capital firm specializing in information and medical technology-based start-ups that has pioneered a shirt-sleeves style of active collaboration with entrepreneurs, to conceive and develop sustainable businesses of significant value.

We've backed nearly 100 companies since 1984, focusing on early-stage and select later stage enterprises in business-to-business markets. Today, we have more than $700 million under management, and an enviable track record: over 80% of ONSET investments have gone on to achieve successive levels of financing, significantly higher than the industry at large.
Contact Onset Ventures:: 2490 Sand Hill Road, Menlo Park, California 94025
650.529.0700
Leslie Bottorff

Profile:: Prospect Venture Partners is a Palo Alto, California based venture capital firm with over $1 billion of capital under management. The firm is dedicated to investing in outstanding biomedical technology and life science companies. Prospect targets commercially attractive health care enterprises with outstanding entrepreneurial management teams, proprietary products, and innovative technology or services with potential for significant investment returns. The firm invests in companies with a broad range of development and financing requirements including: (a) incubating new companies, (b) investing in first and second venture financing rounds, and (c) participating in later stage private and public companies with proven business models requiring expansion capital.

Prospect Venture Partners seeks to ultimately invest $10-20 million in each company in its portfolio, typically as a lead investor or as a co-lead in an investor syndicate. First round investments most often range from $500,000 to $10 million. Prospect Venture Partners typically has representation on the board of directors for each of its portfolio companies.
Contact Prospect Venture Partners:: 435 Tasso Street, Suite 200, Palo Alto, CA 94301
650.327.8800
Russell Hirsch, M.D.

Profile:: Founded in 1979, Sanderling Ventures is amongst the oldest and most established U.S. venture firm focused exclusively on biomedical investing (in the fields of biotechnology, medical devices and information health).

Sanderling focuses on seed and early-stage investing and has developed a unique strategy to enable it to earn consistently high rates of return across multiple vintage years.

Key to Sanderling’s success is the depth of experience of its managers who have a collective 275 years in private equity investing and operational management. The managers have played a leading role in companies that have laid the foundation for the modern biomedical industry including Genentech, Hybritech and Guidant (Advanced Cardiovascular Systems). Most recently, the team has lead some of the largest M&As and IPOs in the industry, including Target Therapeutics ($1.1 bil M&A), Intermune ($125 mil IPO), Cardionet ($81 mil IPO) and Actimis ($515 mil M&A).
Contact Sanderling Ventures:: 400 S. El Camino Real, Suite 1200, San Mateo, CA 94402
650.401.2000
Tim Mills, PhD
Rob Abrams

Profile:: Split Rock Partners, with offices in Minneapolis and Menlo Park, seeks engagement with entrepreneurs and co-investors who share our zeal for emerging opportunities in healthcare and software, and our determination to transform those opportunities into thriving businesses. In healthcare, we specialize in medical device and specialty pharmaceutical opportunities. In software and services, we focus on enterprise software and business and consumer services. Our primary geographic focus is on companies based in the Upper Midwest and West Coast. We are active venture investors in the sectors we target. The investment professionals at Split Rock Partners collectively have more than 80 years of venture investing and company-building experience. Between our four partners, we have founded or co-founded 13 companies and held CEO roles in 8 start-up companies. We focus on working with entrepreneurs collaboratively, building partnerships with them based on integrity and mutual respect, and working together to nurture promising ideas into successful companies. Additional information about the firm can be found at www.splitrockpartners.com.
Contact Split Rock Partners:: 1600 El Camino Real, Suite 290, Menlo Park CA 94025
650.617.1500
Allan Will
Josh Baltzell

Profile:

SV Life Sciences is a venture capital adviser and manager that makes selected investments in businesses with experienced entrepreneurs and management teams.

SV Life Sciences provides finance to businesses at all stages of development and across the human life sciences sector. These sectors range from biotechnology & pharmaceuticals to medical devices & instruments, to healthcare information technology and services. SV Life Sciences currently advises or manages five funds with capital commitments of approximately $1.5 billion which primarily invest amounts of between $1m and $40m in North America and Europe, but will consider innovative investments in other regions. Our team of 32 professionals has a diverse, complimentary set of skills and experience that allow us to tailor a team to work with almost any life sciences business.

Contact SV Life Science Partners:

Metro Center 950 Tower Lane Suite 1725 Foster City, CA 94404
650.571.8200
Jonathan Wyler
David Milne

Profile:: Synergy Life Science Partners is a venture capital firm that helps to form and invests in early stage medical device and combination product (device with a therapeutic payload such as biologics and drugs) companies. We take a synergistic approach with entrepreneurs to build valuable companies through capital allocation, access to our valuable network and our technical, clinical and operational expertise. Synergy focuses on early-stage companies in large therapeutic areas. We seek companies with productive, domain-experienced leadership teams who are winners. We target companies with big ideas that are matched with focused, capital efficient, clinically-driven development plans and sound business models. Our diversified experiences allow and enable us to support the management of companies, both technically and operationally, to enable these companies to scale and prosper.
Contact Synergy Life Science Partners:: 3282 Alpine Road, Portola Valley, CA 94028
650.854.7155
Mudit Jain, PhD

Profile:: U.S. Venture Partners is a venture capital management Firm that invests pri marily in early stage technology, medical, and consumer companies. USVP's objec tive is to finance, and help to build well-managed enterprises of significant va lue in its targeted industry sectors. The Firm seeks people with skills, experie nce, vision, energy and persistence, and is proactive in supporting the entrepre neurs in the identification and achievement of their business objectives. USVP is one of the larger and more prominent venture capital firms on the West Coast. With the significant record of extensive direct operating experience of its partners and as a lead early round investor in many successful companies, the Firm has the ability to provide capital, counsel, financial and management expertise and access through a broad network of relationships.
Contact USVP:: 2735 Sand Hill Road, Menlo Park, CA 94025
650.854.9080; Alan Kaganov, ScD
Jonathan Root, MD
Phil Young

Profile:: Versant Ventures is a leading healthcare-focused venture capital firm specializing in early-stage investments in medical devices, biotechnology and pharmaceuticals, healthcare services, and healthcare information technology. The firm, founded in 1999, consists of a seasoned team of twelve managing directors with more than 130 years of venture capital investing experience and more than 150 years of operating experience.; Versant Ventures currently manages over $1 billion in committed capital having recently raised its third fund in November 2005, and is currently managing over 75 companies in its portfolio.
Contact Versant Ventures:: 3000 Sand Hill Road, Bldg.4, Suite 210, Menlo Park, CA 94025
650.233.7877
Ross Jaffe, MD
Beckie Robertson
Kevin Wasserstein